Technology
Live Price
Offline$27.35
+1.60% today
1Y Change
-5.26%
Window
Jun 25, 2025 β Jun 17, 2026
Coverage: 246 bars Β· Jun 25, 2025 β Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
CANON INC (CAJPY) is a Technology stock with a market cap of $3.49T and listed on OTC. The stock last traded around $27.35 and down 5.3% across the available one-year price window (Jun 25, 2025 β Jun 17, 2026). Baseline metrics include revenue growth of +7.5%, EPS growth of +132.8%, a dividend yield of 4.0%. What stands out right now is revenue +7.5%, EPS +132.8%, free cash flow -39.4% with operating margin 9.2% and ROIC 6.1%. The dividend matters to the case here, with a current yield around 4.0%. Valuation is more restrained than many high-expectation growth names at P/E 11.4 and price/sales 0.7. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines CAJPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+7.5% vs +11.9% peer median
Operating Margin
Below sector median
+9.2% vs +22.0% peer median
P/E
Below sector median
11.4 vs 18.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 23, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +7.5% and EPS at +132.8%, with operating margin around 9.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 4.0%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.4% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 23, 2026 | β | -2.1% | -0.7% | +1.7% |
2026 Jan 29, 2026 | +35.5% | -2.7% | -0.6% | -2.9% |
2025 Oct 27, 2025 | +0.4% | -1.5% | -2.8% | -2.3% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CAJPY
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CAJPY Max Drawdown
-22.23%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for CAJPY and SPY.
Company Overview
CANON INC
OTC
Canon Inc. Sponsored ADR represents the American Depositary Receipt (ADR) for Canon Inc., a global leader in imaging and optical products headquartered in Tokyo, Japan. The ADR structure allows U.S. investors to gain exposure to Canonβs shares without trading directly on overseas markets. Canon Inc. operates across four main divisions: printing, imaging, medical, and industrial. Its printing segment is the largest, encompassing office multifunction devices, laser and inkjet printers, document solutions, and large-format presses. The imaging division includes digital cameras, lenses, and broadcast equipment, while the medical segment offers diagnostic imaging systems and healthcare IT solutions. The industrial segment provides advanced semiconductor and display manufacturing equipment. Canonβs diverse portfolio serves businesses and consumers worldwide, positioning the company as a significant player in technology-driven industries. The Sponsored ADR trades over-the-counter, making it accessible to a broad range of global investors, and its operational scale reflects Canonβs central role in both consumer electronics and specialized industrial markets.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.